Sam Chun Dang Pharm. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	84,205	95,944	105,585	40,427	22,101	49,113
Short-Term Investments	1,522	8,024	35,305	41,006	43,960	42,048
Trading Asset Securities	24,641	25,090	1,027	11,311	20,188	10,863
Cash & Short-Term Investments	110,369	129,058	141,917	92,744	86,248	102,025
Cash Growth	-13.53%	-9.06%	53.02%	7.53%	-15.46%	0.06%
Accounts Receivable	54,312	45,577	35,537	30,426	34,954	31,863
Other Receivables	12,989	9,849	22,977	4,644	3,494	2,698
Receivables	67,950	55,641	61,387	35,111	39,004	38,589
Inventory	48,705	52,613	38,191	35,263	31,913	27,908
Prepaid Expenses	1,541	1,896	687.39	451.24	113.26	137.53
Other Current Assets	11,731	2,550	350.36	337.11	470.48	260.25
Total Current Assets	240,295	241,759	242,532	163,906	157,749	168,920
Property, Plant & Equipment	150,448	143,094	103,595	90,009	87,212	74,112
Long-Term Investments	16,488	16,458	30,445	32,899	32,712	38,399
Goodwill	3,745	3,745	3,745	3,745	3,745	3,745
Other Intangible Assets	29,945	29,434	27,585	14,126	15,177	15,175
Long-Term Accounts Receivable	0	-0	-0	-0	0	0
Long-Term Deferred Tax Assets	8,241	8,315	8,677	16,602	7,731	13,226
Long-Term Deferred Charges	102,174	96,577	90,856	78,429	61,918	27,461
Other Long-Term Assets	17,353	17,531	8,435	3,583	3,588	2,871
Total Assets	573,120	561,231	519,772	408,022	372,793	343,948
Accounts Payable	4,222	4,695	4,848	3,862	4,943	4,758
Accrued Expenses	27,612	25,043	15,688	11,428	10,865	8,328
Short-Term Debt	11,710	11,784	12,290	12,226	2,756	1,580
Current Portion of Long-Term Debt	33,000	33,000	16,000	20,000	-	20,000
Current Portion of Leases	1,667	1,624	1,536	1,470	1,330	713.57
Current Income Taxes Payable	7,415	1,428	21,226	1,298	576.79	1,098
Current Unearned Revenue	6,287	6,287	151.77	137.94	68.14	-
Other Current Liabilities	18,067	22,710	21,681	7,535	17,621	17,541
Total Current Liabilities	109,981	106,572	93,421	57,957	38,160	54,019
Long-Term Debt	-	21,032	17,000	16,000	67,822	26,060
Long-Term Leases	2,347	2,391	3,115	3,929	4,683	3,188
Long-Term Unearned Revenue	57,807	59,288	44,610	19,208	7,418	-
Pension & Post-Retirement Benefits	7,753	7,607	11,398	12,315	8,922	10,314
Other Long-Term Liabilities	756.72	748.13	824.08	152.9	147.25	66.35
Total Liabilities	178,646	197,638	170,368	109,562	127,151	93,647
Common Stock	11,729	11,729	11,729	11,729	11,384	11,384
Additional Paid-In Capital	184,939	167,540	158,174	102,853	50,496	50,124
Retained Earnings	100,224	95,965	95,452	106,015	112,079	112,514
Treasury Stock	-142.04	-566.94	-568.09	-1,988	-1,988	-1,988
Comprehensive Income & Other	1,465	1,353	1,319	1,889	1,771	2,060
Total Common Equity	298,215	276,020	266,105	220,499	173,741	174,095
Minority Interest	96,260	87,574	83,299	77,961	71,901	76,206
Shareholders' Equity	394,474	363,593	349,404	298,460	245,642	250,301
Total Liabilities & Equity	573,120	561,231	519,772	408,022	372,793	343,948
Total Debt	48,724	69,831	49,941	53,625	76,590	51,541
Net Cash (Debt)	61,645	59,227	91,975	39,119	9,658	50,484
Net Cash Growth	-20.42%	-35.61%	135.12%	305.04%	-80.87%	-32.59%
Net Cash Per Share	2633.22	2546.56	3993.76	1718.95	437.65	2287.64
Filing Date Shares Outstanding	23.38	23.26	23.26	22.76	22.07	22.07
Total Common Shares Outstanding	23.38	23.26	23.26	22.76	22.07	22.07
Working Capital	130,314	135,187	149,112	105,949	119,590	114,901
Book Value Per Share	12752.91	11867.79	11441.71	9689.07	7872.97	7889.00
Tangible Book Value	264,524	242,841	234,775	202,627	154,819	155,175
Tangible Book Value Per Share	11312.17	10441.22	10094.60	8903.78	7015.53	7031.64
Land	16,224	16,224	16,224	16,224	15,423	15,529
Buildings	25,383	25,772	27,186	50,909	50,664	46,430
Machinery	32,153	31,971	28,720	59,829	56,280	43,220
Construction In Progress	72,461	64,821	26,187	19,473	13,800	14,923